Geoffrey R Nunns1, John R Stringham2, Fabia Gamboni2, Ernest E Moore3, Miguel Fragoso3, Gregory R Stettler2, Christopher C Silliman4, Anirban Banerjee2. 1. School of Medicine, Department of Surgery, Trauma Research Center, University of Colorado Denver, Aurora, Colorado. Electronic address: geoffrey.nunns@ucdenver.edu. 2. School of Medicine, Department of Surgery, Trauma Research Center, University of Colorado Denver, Aurora, Colorado. 3. School of Medicine, Department of Surgery, Trauma Research Center, University of Colorado Denver, Aurora, Colorado; Denver Health Medical Center, Department of Surgery, Denver, Colorado. 4. School of Medicine, Department of Surgery, Trauma Research Center, University of Colorado Denver, Aurora, Colorado; School of Medicine, Department of Pediatrics-Hematology/Oncology, Children's Hospital Colorado, University of Colorado Denver, Aurora, Colorado; Research Laboratory, Bonfils Blood Center, Denver, Colorado.
Abstract
BACKGROUND: Post-traumatic lung injury following trauma and hemorrhagic shock (T/HS) is associated with significant morbidity. Leukotriene-induced inflammation has been implicated in the development of post-traumatic lung injury through a mechanism that is only partially understood. Postshock mesenteric lymph returning to the systemic circulation is rich in arachidonic acid, the substrate of 5-lipoxygenase (ALOX5). ALOX5 is the rate-limiting enzyme in leukotriene synthesis and, following T/HS, contributes to the development of lung dysfunction. ALOX5 colocalizes with its cofactor, 5-lipoxygenase-activating protein (ALOX5AP), which is thought to potentiate ALOX5 synthetic activity. We hypothesized that T/HS results in the molecular association and nuclear colocalization of ALOX5 and ALOX5AP, which ultimately increases leukotriene production and potentiates lung injury. MATERIALS AND METHODS: To examine these molecular interactions, a rat T/HS model was used. Post-T/HS tissue was evaluated for lung injury through both histologic analysis of lung sections and biochemical analysis of bronchoalveolar lavage fluid. Lung tissue was immunostained for ALOX5 and ALOX5AP with association and colocalization evaluated by fluorescence resonance energy transfer. In addition, rats undergoing T/HS were treated with MK-886, a known ALOX5AP inhibitor. RESULTS: ALOX5 levels increase and ALOX5/ALOX5AP association occurred after T/HS, as evidenced by increases in total tissue fluorescence and fluorescence resonance energy transfer signal intensity, respectively. These findings coincided with increased leukotriene production and with the histological changes characteristic of lung injury. ALOX5/ALOX5AP complex formation, leukotriene production, and lung injury were decreased after inhibition of ALOX5AP with MK-886. CONCLUSIONS: These results suggest that the association of ALOX5/ALOX5AP contributes to leukotriene-induced inflammation and predisposes the T/HS animal to lung injury.
BACKGROUND: Post-traumatic lung injury following trauma and hemorrhagic shock (T/HS) is associated with significant morbidity. Leukotriene-induced inflammation has been implicated in the development of post-traumatic lung injury through a mechanism that is only partially understood. Postshock mesenteric lymph returning to the systemic circulation is rich in arachidonic acid, the substrate of 5-lipoxygenase (ALOX5). ALOX5 is the rate-limiting enzyme in leukotriene synthesis and, following T/HS, contributes to the development of lung dysfunction. ALOX5 colocalizes with its cofactor, 5-lipoxygenase-activating protein (ALOX5AP), which is thought to potentiate ALOX5 synthetic activity. We hypothesized that T/HS results in the molecular association and nuclear colocalization of ALOX5 and ALOX5AP, which ultimately increases leukotriene production and potentiates lung injury. MATERIALS AND METHODS: To examine these molecular interactions, a rat T/HS model was used. Post-T/HS tissue was evaluated for lung injury through both histologic analysis of lung sections and biochemical analysis of bronchoalveolar lavage fluid. Lung tissue was immunostained for ALOX5 and ALOX5AP with association and colocalization evaluated by fluorescence resonance energy transfer. In addition, rats undergoing T/HS were treated with MK-886, a known ALOX5AP inhibitor. RESULTS:ALOX5 levels increase and ALOX5/ALOX5AP association occurred after T/HS, as evidenced by increases in total tissue fluorescence and fluorescence resonance energy transfer signal intensity, respectively. These findings coincided with increased leukotriene production and with the histological changes characteristic of lung injury. ALOX5/ALOX5AP complex formation, leukotriene production, and lung injury were decreased after inhibition of ALOX5AP with MK-886. CONCLUSIONS: These results suggest that the association of ALOX5/ALOX5AP contributes to leukotriene-induced inflammation and predisposes the T/HS animal to lung injury.
Authors: Benjamin M Howard; Lucy Z Kornblith; Carolyn M Hendrickson; Brittney J Redick; Amanda S Conroy; Mary F Nelson; Rachael A Callcut; Carolyn S Calfee; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2015-04 Impact factor: 3.313
Authors: Phillip C Eckels; Anirban Banerjee; Ernest E Moore; Nathan J D McLaughlin; Lynn M Gries; Marguerite R Kelher; Kelly M England; Fabia Gamboni-Robertson; Samina Y Khan; Christopher C Silliman Journal: Am J Physiol Cell Physiol Date: 2009-03-18 Impact factor: 4.249
Authors: Bryce R H Robinson; Mitchell J Cohen; John B Holcomb; Timothy A Pritts; Dina Gomaa; Erin E Fox; Richard D Branson; Rachael A Callcut; Bryan A Cotton; Martin A Schreiber; Karen J Brasel; Jean-Francois Pittet; Kenji Inaba; Jeffery D Kerby; Thomas M Scalea; Charlie E Wade; Eileen M Bulger Journal: Shock Date: 2018-09 Impact factor: 3.454
Authors: Andrew D Ferguson; Brian M McKeever; Shihua Xu; Douglas Wisniewski; Douglas K Miller; Ting-Ting Yamin; Robert H Spencer; Lin Chu; Feroze Ujjainwalla; Barry R Cunningham; Jilly F Evans; Joseph W Becker Journal: Science Date: 2007-06-28 Impact factor: 47.728
Authors: Ying Chen; Zhipeng Xu; Qi Song; Zhenjie Wang; Zhong Ji; Zhaolei Qiu; Feng Cheng; Hai Jiang Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2019-10-30
Authors: J Michael; M S Unger; R Poupardin; P Schernthaner; H Mrowetz; J Attems; L Aigner Journal: Acta Neuropathol Commun Date: 2020-08-08 Impact factor: 7.801